Owing to the previously reported ectodomain shedding of TMEFF2 upon treatment of A172 glioma cells with TNFα and interleukin-1 [66], Knauper’s group investigated TMEFF2 as a substrate of ADAM proteases. Here, TMEFF2 is linked to central nervous system cancer.